Novakovic Boris, Napier Christine E, Vryer Regan, Dimitriadis Eva, Manuelpillai Ursula, Sharkey Andrew, Craig Jeffrey M, Reddel Roger R, Saffery Richard
Murdoch Childrens Research Institute-Cancer and Disease Epigenetics, Royal Children's Hospital Flemington Road, Parkville, Melbourne, Victoria 3052, Australia.
Cancer Research Unit, Children's Medical Research Institute, The University of Sydney, Westmead, NSW 2145, Australia.
Mol Hum Reprod. 2016 Nov;22(11):791-799. doi: 10.1093/molehr/gaw053. Epub 2016 Sep 7.
What factors regulate elongated telomere length in the human placenta?
Hypomethylation of TERRA promoters in the human placenta is associated with high TERRA expression, however, no clear mechanistic link between these phenomena and elongated telomere length in the human placenta was found.
Human placenta tissue and trophoblasts show longer telomere lengths compared to gestational age-matched somatic cells. However, telomerase (hTERT) expression and activity in the placenta is low, suggesting a role for an alternative lengthening of telomeres (ALT). While ALT is observed in 10-15% of human cancers and in some mouse stem cells, ALT has never been reported in non-cancerous human tissues.
STUDY DESIGN, SAMPLES/MATERIALS, METHODS: Human term placental tissue and matched cord blood mononuclear cells (CBMCs) were collected as part of the Peri/Postnatal Epigenetic Twins study (PETS). In addition, first trimester placental villi, purified cytotrophoblasts, choriocarcinoma cell lines and a panel of ALT-positive cancer cell lines were tested. Telomere length was determined using the Terminal Restriction Fragment (TRF) assay and a relative quantitative PCR method. DNA methylation levels at several CpG rich subtelomeric TERRA promoters were determined using bisulfite conversion and the SEQUENOM EpiTYPER platform. Expression of TERRA and hTERT was determined using quantitative RT-PCR. ALT was assessed using the C-circle assay (CCA).
The human placenta tissue and purified first trimester trophoblasts showed low subtelomeric (TERRA) DNA methylation compared to matched CBMCs and other somatic cells. Interestingly placental TERRA methylation was lower than ALT-cancer cell lines, previously reported to be hypomethylated at these loci. Low TERRA methylation was associated with higher expression of TERRA RNA in placenta compared to matched CBMCs. Detectable levels of C-circles were observed in first trimester placental villi, but not term placenta, suggesting that the ALT mechanism may be active in specific placental cells in early gestation. C-circle analysis of purified first trimester trophoblasts and ALT-associated PML bodies (APB) staining of first trimester villi cross-sections failed to identify this specific cell type population.
LIMITATIONS, REASONS FOR CAUTION: While first trimester villi showed detectable levels of C-circles, these levels were very low compared with those observed in ALT-positive tumours and cell lines. This is consistent with a small sub-population of ALT-positive cells but this requires further investigation. Finally, no mechanistic link was established between TERRA DNA methylation, the presence of C-circles and longer telomere length.
Given the previously described role of TERRA ncRNA as a negative regulator of telomerase, the finding of elevated TERRA and long telomeres is counterintutive. ALT as a mechanism for telomere length maintenance has only been reported in certain human cancers, and recently in mouse embryonic stem cells and embryos. As with many aspects of cancer, it appears that ALT activity in tumours may be the inappropriate activation of a pathway found in very specific cell types in human development. Our data are the first supportive evidence for ALT in a non-cancerous human tissue, a result that requires further investigation and replication. The level of TERRA methylation in the human placenta is significantly lower than found in ALT cancer cell lines and somatic cells, raising the possibility of a novel mechanism in maintaining low methylation at subtelomeric regions.
Not applicable.
This study was supported by NHMRC early career fellowship (B.N.), NHMRC Senior Research Fellowship (R.S.) and the Victoria Government Infrastructure Grant. R.R. holds a patent for the C-circle assay. No other conflicts declared.
哪些因素调节人类胎盘中延长的端粒长度?
人类胎盘中TERRA启动子的低甲基化与TERRA高表达相关,然而,未发现这些现象与人类胎盘端粒长度延长之间存在明确的机制联系。
与孕周匹配的体细胞相比,人类胎盘组织和滋养层细胞显示出更长的端粒长度。然而,胎盘中端粒酶(hTERT)的表达和活性较低,提示端粒替代延长(ALT)发挥了作用。虽然在10%-15%的人类癌症以及一些小鼠干细胞中观察到了ALT,但从未在非癌性人类组织中报道过。
研究设计、样本/材料、方法:作为围产期/产后表观遗传双胞胎研究(PETS)的一部分,收集了人类足月胎盘组织和匹配的脐带血单个核细胞(CBMC)。此外,还检测了孕早期胎盘绒毛、纯化的细胞滋养层细胞、绒毛膜癌细胞系和一组ALT阳性癌细胞系。使用末端限制片段(TRF)分析和相对定量PCR方法测定端粒长度。使用亚硫酸氢盐转化和SEQUENOM EpiTYPER平台测定几个富含CpG的亚端粒TERRA启动子处的DNA甲基化水平。使用定量RT-PCR测定TERRA和hTERT的表达。使用C环分析(CCA)评估ALT。
与匹配的CBMC和其他体细胞相比,人类胎盘组织和纯化的孕早期滋养层细胞显示出较低的亚端粒(TERRA)DNA甲基化。有趣的是,胎盘TERRA甲基化低于ALT癌细胞系,此前报道这些位点在ALT癌细胞系中是低甲基化的。与匹配的CBMC相比,胎盘TERRA低甲基化与TERRA RNA的高表达相关。在孕早期胎盘绒毛中观察到可检测水平的C环,但足月胎盘未观察到,这表明ALT机制可能在妊娠早期的特定胎盘细胞中活跃。对纯化的孕早期滋养层细胞进行C环分析以及对孕早期绒毛横截面进行ALT相关的早幼粒细胞白血病蛋白体(APB)染色,均未鉴定出这种特定的细胞类型群体。
局限性、注意事项:虽然孕早期绒毛显示出可检测水平的C环,但与ALT阳性肿瘤和细胞系中观察到的水平相比,这些水平非常低。这与一小部分ALT阳性细胞一致,但这需要进一步研究。最后,未在TERRA DNA甲基化、C环的存在与更长端粒长度之间建立机制联系。
鉴于先前描述的TERRA非编码RNA作为端粒酶负调节因子的作用,TERRA升高和端粒延长的发现与直觉相反。ALT作为端粒长度维持的一种机制仅在某些人类癌症中报道过,最近在小鼠胚胎干细胞和胚胎中也有报道。与癌症的许多方面一样,肿瘤中的ALT活性似乎可能是人类发育中非常特定细胞类型中发现的一种途径的不适当激活。我们的数据是ALT在非癌性人类组织中的首个支持性证据,这一结果需要进一步研究和验证。人类胎盘中TERRA甲基化水平显著低于ALT癌细胞系和体细胞中的水平,这增加了在亚端粒区域维持低甲基化的新机制的可能性。
不适用。
本研究得到了澳大利亚国家卫生与医学研究委员会(NHMRC)早期职业奖学金(B.N.)、NHMRC高级研究奖学金(R.S.)以及维多利亚州政府基础设施资助。R.R.拥有C环分析的专利。未声明其他冲突。